AGE AS A KEY RISK FACTOR FOR SEVERE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN: A LITERATURE REVIEW
Authors:
- Agata RapiorARAgata Rapior
- Julia GroszewskaJGJulia Groszewska
- Agata MytychAMAgata Mytych
- Michał RomaniukMRMichał Romaniuk
- Daria Julia Makowska-WoszczykDMDaria Julia Makowska-Woszczyk
- Kinga LubomskaKLKinga Lubomska
- Patrycja JaguraPJPatrycja Jagura
- Jan RomaniukJRJan Romaniuk
- Marta DziedziakMDMarta Dziedziak
- Łukasz NosekŁNŁukasz Nosek
Open Access
- 6 January 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
Abstract
Research Objectives: Respiratory Syncytial Virus (RSV) is a leading cause of lower respiratory tract infections in young children, particularly in infants under six months. This review aims to synthesize recent clinical and epidemiological data to identify age groups at the highest risk for severe RSV disease. Methods: A systematic literature search was conducted in PubMed for studies published between 2020 and 2025, focusing on pediatric populations aged 0–5 years with laboratory-confirmed RSV infection. Cohort, prospective, and retrospective studies, as well as clinical guidelines, reporting hospitalization rates, intensive care unit admissions, oxygen therapy, and risk factors such as prematurity and comorbidities were included. Data were analyzed narratively to assess relationships between age, prematurity, comorbidities, and disease severity. Key Findings: The youngest infants (0–5 months) accounted for most hospitalizations and were most likely to require intensive care. Prematurity increased hospitalization risk approximately with earlier gestational age correlating with higher severity. Comorbidities further elevated the risk of prolonged hospitalization and intensive care, especially in older children. Introduction of RSV prophylaxiy substantially reduced hospitalization rates among infants, particularly those 0–2 months. Seasonal trends and epidemiological shifts, influenced by the COVID-19 pandemic, affected RSV incidence and severity. Conclusions: Age is the primary determinant of severe RSV outcomes, with prematurity and comorbidities acting as significant modifiers. Early identification of high-risk infants and targeted prophylactic strategies are essential to reduce hospitalization and optimize healthcare resource allocation. Continuous monitoring and evaluation of prevention strategies across age groups remain crucial.Keywords
This publication has 14 references indexed in Scilit:
- Risk factors associated with severe RSV disease among hospitalized children in the second year of life: a multicenter studyEuropean Journal of Pediatrics, 2025
- Risk Factors for Severe Disease Among Children Hospitalized With Respiratory Syncytial VirusJAMA Network Open, 2025
- Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infantsBMC Infectious Diseases, 2024
- Respiratory Syncytial Virus Hospital-Based Burden of Disease in Children Younger Than 5 Years, 2015-2022JAMA Network Open, 2024
- Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virusNature Communications, 2024
- Age‐specific predictors of disease severity in children with respiratory syncytial virus infection beyond infancy and through the first 5 years of agePediatric Allergy and Immunology, 2024
- Trends in Age and Disease Severity in Children Hospitalized With RSV Infection Before and During the COVID-19 PandemicJAMA Pediatrics, 2024
- The disease burden of respiratory syncytial virus in InfantsCurrent Opinion in Infectious Diseases, 2023
- Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administrationHuman Vaccines & Immunotherapeutics, 2023
- Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomesInfluenza and Other Respiratory Viruses, 2020